ESHELMAN FREDRIC N 4
4 · G1 Therapeutics, Inc. · Filed Jun 12, 2020
Insider Transaction Report
Form 4
ESHELMAN FREDRIC N
Director10% Owner
Transactions
- Award
Stock Option (right to buy)
2020-06-11+20,000→ 20,000 totalExercise: $17.59Exp: 2030-06-11→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option will vest in their entirety twelve months after June 11, 2020, subject to the Reporting Person's continued service as a director.